Does RISANKIZUMAB-RZAA Cause Off label use? 718 Reports in FDA Database
Visibly Younger Skin in Weeks
Synevra Lift & Lock — Swiss peptide serum + nutrients. 60-day money-back guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 718 reports of Off label use have been filed in association with RISANKIZUMAB-RZAA. This represents 1.1% of all adverse event reports for RISANKIZUMAB-RZAA.
718
Reports of Off label use with RISANKIZUMAB-RZAA
1.1%
of all RISANKIZUMAB-RZAA reports
3
Deaths
58
Hospitalizations
How Dangerous Is Off label use From RISANKIZUMAB-RZAA?
Of the 718 reports, 3 (0.4%) resulted in death, 58 (8.1%) required hospitalization, and 1 (0.1%) were considered life-threatening.
Is Off label use Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for RISANKIZUMAB-RZAA. However, 718 reports have been filed with the FAERS database.
What Other Side Effects Does RISANKIZUMAB-RZAA Cause?
Psoriasis (6,896)
Drug ineffective (2,885)
Pain (2,584)
Fatigue (2,483)
Arthralgia (2,419)
Pruritus (2,311)
Covid-19 (2,145)
Death (1,700)
Fall (1,666)
Surgery (1,662)
What Other Drugs Cause Off label use?
RITUXIMAB (39,751)
INFLIXIMAB (34,801)
DENOSUMAB (34,612)
METHOTREXATE (24,020)
VEDOLIZUMAB (21,017)
ETANERCEPT (20,178)
TOCILIZUMAB (18,256)
PREDNISONE (17,867)
LENALIDOMIDE (17,017)
ADALIMUMAB (16,417)
Which RISANKIZUMAB-RZAA Alternatives Have Lower Off label use Risk?
RISANKIZUMAB-RZAA vs RISDIPLAM
RISANKIZUMAB-RZAA vs RISEDRONATE
RISANKIZUMAB-RZAA vs RISEDRONIC ACID
RISANKIZUMAB-RZAA vs RISPERDAL
RISANKIZUMAB-RZAA vs RISPERDAL CONSTA